Submit Deal

Submit Deal

Cover Image Ruth Gimeno

Ruth Gimeno

Vice President of Diabetes and Metabolic Research at ELI LILLY AND COMPANY

Manager

Deal Bio

Total Deals4

Valued Deals4

Total Value£ 2.46 B

Avg. Deal Size£ 616 M

Market Context

Sort

20 Nov 2020|United States|Biotechnology

Target: PRECISION BIOSCIENCES

Bidder: ELI LILLY AND COMPANY

3 Service Providers

1 Target | 2 Bidder

7 Dealmakers

1 Target | 7 Bidder

£ 25 M

Value

14 Jul 2021|United States|Biotechnology

Target: PROTOMER TECHNOLOGIES

Bidder: ELI LILLY AND COMPANY

5 Service Providers

3 Target | 2 Bidder

16 Dealmakers

6 Target | 10 Bidder

£ 722 M

Value

29 Jun 2023|United States|Biotechnology

Target: SIGILON THERAPEUTICS INC

Bidder: ELI LILLY AND COMPANY

7 Service Providers

5 Target | 2 Bidder

18 Dealmakers

14 Target | 4 Bidder

£ 244 M

Value

14 Jul 2023|United States|Biotechnology

Target: VERSANIS

Bidder: ELI LILLY AND COMPANY

7 Service Providers

5 Target | 2 Bidder

26 Dealmakers

8 Target | 18 Bidder

£ 1.47 B

Value

Privacy Policy Terms of Service Contact Us Cookie Preferences

All rights reserved. Copyright © 2025 Datasite